European VC Directory

Venture capital firm investing in high-growth technology companies.

Armira

DE

Armira invests in German mid-market companies and resilient growth businesses, prioritizing long-term alignment with investors and partner companies. Their approach is built on trust, sustainability, and responsible decision-making.

Venture capital firm investing in high-growth technology companies.

Arrowfield Stud, established in 1985, stands as one of the world's foremost thoroughbred stud farms. Founded by John Messara AM, it gained prominence as the launch-pad for breed-shaper Danehill and the home of Champion Sires Redoute’s Choice, Flying Spur, Not A Single Doubt & Snitzel. The stud has been the source of 88 Group 1 winners and the vendor of 85 million-dollar yearlings since 2001. Arrowfield employs 120 people across its stallion, broodmare, yearling, and racing operations. Located on 2500 acres in the fertile Segenhoe Valley near Scone, in the Upper Hunter region of New South Wales, Australia, Arrowfield is dedicated to breeding and raising elite equine athletes. The stud's commitment extends to realizing the racing dreams of its clients through a combination of first-class personnel and exceptional thoroughbreds. Arrowfield continues to shape the landscape of thoroughbred breeding and racing on a global scale.

Art-Invest Real Estate

Cologne, DE

Art-Invest Real Estate positions itself as a project developer, asset manager, and long-term investor focused on creating sustainable value in the real estate market. Their approach centers around innovation, creativity, and a commitment to projects that positively impact society and the environment. They emphasize creating added value for all stakeholders, not just for themselves, and aim to shape the future through responsible and sustainable development.

Venture capital firm investing in high-growth technology companies.

Arweave

GB

Arweave's investment thesis centers around permanent and decentralized data storage. They envision a future where critical information is preserved indefinitely and web applications operate in a truly decentralized and neutral environment. The Arweave network operates as a permanent, decentralized web built within an open ledger, similar to Bitcoin but for data, and has wide adoption, with a stable and mature protocol. The company focuses on supporting applications that leverage this permanent storage for various uses, including preservation of important data and development of decentralized applications. Arweave's strategy appears to be ecosystem-centric, as the website describes itself as a map guiding users to learn about, use, and build on Arweave. It focuses on developing a community around this permaweb. Investment is likely directed towards developers and companies contributing to the Arweave ecosystem. Arweave's strategy is oriented towards promoting growth and adoption of permaweb technology by expanding the number of applications and use-cases, demonstrating its reliability, and developing a community.

Venture capital firm investing in high-growth technology companies.

Ascend Capital Partners

LU

Ascend Capital Partners invests in early-stage disruptors in MedTech and Mobility with global scaling potential. They build ecosystems by investing in complementary technologies and act as long-term, founder-first partners to drive growth and unlock potential across cross-border markets.

Ascenion

Munich, DE

Ascenion GmbH is a knowledge and technology transfer company focused on academic life science research. They operate as a bridge between research institutions and industry, aiming to protect, develop, and commercialize innovative ideas. Ascenion initiates and finances start-ups, provides services to inventors and founders, and helps industry and investors discover opportunities for innovation. They manage a portfolio of over 700 technologies and research materials, facilitating the transfer of these assets to companies that can further develop and commercialize them. Their activities span from initial IP protection and development to financing and strategic support for start-ups, and ultimately to licensing and partnerships with established industry players. Ascenion's core strategy revolves around identifying promising research outputs from its partner institutes, securing intellectual property, and then de-risking and developing these technologies to a point where they are attractive for commercialization. This often involves initiating and supporting start-up companies, providing them with seed funding, management expertise, and access to Ascenion's network of industry contacts. The firm also works closely with established companies to license and co-develop technologies, creating value for both the research institutions and the industry partners. Ascenion's partnership with the LifeScience Foundation underlines its commitment to translating academic discoveries into real-world applications. The company plays a critical role in the life science ecosystem by accelerating the development and commercialization of innovative technologies, ultimately contributing to advancements in healthcare and other related fields. They also actively engage in knowledge sharing and collaboration through workshops and events, fostering a vibrant community of technology transfer professionals and entrepreneurs.

Venture capital firm investing in high-growth technology companies.

Ascenta Capital

Ascenta Capital invests in early-stage biotech companies with scientific foundations, focusing on translating preclinical science into early human safety and efficacy data. They provide strategic support, operational expertise, and capital to help partners scale effectively, prioritizing patient-centered innovations with transformative potential.

Venture capital firm investing in high-growth technology companies.

AshGrove Capital

London, GB

Provides bespoke capital and financing solutions for founder-led and sponsor-backed companies with resilient business models, offering flexible growth support.

Venture capital firm investing in high-growth technology companies.

Asia Pacific Investment Partners (APIP) focuses on investments in emerging markets across Asia. The firm's strategy revolves around identifying and capitalizing on opportunities in developing economies with high growth potential. APIP's investment approach extends to various sectors including real estate, construction, food and beverage retail, and metals. The company focuses on long-term investments and aims to foster sustainable growth within its portfolio companies, positioning itself as a strategic partner in the development of emerging economies. Their research division provides deep insights into the economies of countries like Mongolia, Myanmar, China, and others, allowing for informed investment decisions. APIP's strategy includes a mix of direct investments and operational involvement in its portfolio companies, showcasing a hands-on approach to value creation and growth.

Asian Development Bank Ventures (ADBV)

Manila, PH

The Asian Development Bank (ADB) focuses on fostering inclusive, resilient, and sustainable development in Asia and the Pacific by addressing poverty, economic growth, and climate change. It provides financing, technical expertise, and partnerships to support member countries in achieving long-term development goals, including infrastructure, healthcare, education, and environmental sustainability.

Asif Ventures

Amsterdam, NL

ASIF Ventures is an Amsterdam-based VC fund supporting student and recent graduate founders from the University of Amsterdam (UvA) and Vrije Universiteit (VU) from the very beginning. Founded in 2017 by students, ASIF was created to back young founders when traditional investors wouldn't. They aim to give students and recent graduates in Amsterdam a real shot at entrepreneurship, backing bold ideas at their earliest stage with capital, community, guidance, and belief. ASIF does more than just invest; they connect founders with the resources, network, and guidance they need to turn ideas into real companies, serving as a launchpad for future entrepreneurs. ASIF targets early-stage funding opportunities for student and recent graduate-led startups in Amsterdam. They provide not only financial capital but also act as a community, offering guidance and support to these young founders. Their focus is on backing bold ideas at their earliest stage, where traditional investors may be hesitant. Their mission encompasses more than just providing funds. They aim to create a supportive ecosystem that includes access to resources, a strong network, and mentorship to help transform ideas into successful businesses. ASIF wants to be the platform that helps future entrepreneurs launch their companies. They've supported 25 startups since inception.

Askeladden & Co

Oslo, NO

Askeladden & Co focuses on enabling great entrepreneurs to build great companies, particularly those that simplify the lives of customers and employees through technology. They identify opportunities by researching industries and companies, aiming to create significant value and improve the lives of colleagues, customers, and society. Their approach involves co-founding companies, providing capital to develop a concept and achieve product-market fit, and offering operational support to handle administrative tasks. They look for companies that can achieve profitable growth, aligning with their business principles of providing high-quality, affordable goods to customers, sustainable jobs for colleagues, and benefiting society through innovation and value creation.

Aspire11

CZ

Aspire11 channels European pension capital into long-term investments in category-defining global tech companies and leading venture funds, emphasizing deeptech, AI, and data infrastructure. Their dual strategy combines direct investing with access to exceptional venture managers, supporting companies through high-growth phases and multi-decade horizons.

Aspirity Partners

London, GB

Aspirity partners with European Financial and Enterprise Technology companies leveraging long-term secular trends to accelerate value through partnership-driven, flexible capital deployment across majority and minority ownership positions.

Venture capital firm investing in high-growth technology companies.

Venture capital firm investing in high-growth technology companies.

Astellas Venture Management LLC

South San Francisco, US

Astellas Venture Management (AVM) is the wholly-owned venture capital organization within Astellas Pharma, dedicated to supporting pre-clinical, cutting-edge science that can bring value to patients. With over 20 years of experience, AVM provides equity investments to private, early-stage companies developing therapeutic programs and platform technologies, helping them advance their innovations faster. AVM operates as a strategic investor, focusing on science that enhances the current Astellas R&D pipeline or catalyzes new directions in discovery research. Their investment approach is grounded in a "Pharma View," leveraging their extensive experience in the pharmaceutical industry to provide portfolio companies with invaluable information and expertise to support their growth. Furthermore, AVM can facilitate dialogue between its portfolio companies and Astellas Pharma for potential future collaborations. AVM targets privately owned early-stage biotechnology companies focused on therapeutics programs and platform technologies for drug discovery and development. To be considered for equity investment, the program stage should be in the preclinical phase. Their areas of interest align with the innovative therapeutic approaches that mirror Astellas Pharma's R&D strategy, particularly those addressing unmet medical needs and offering unprecedented treatments that are likely to be realized in the near future. AVM differentiates itself by providing portfolio companies with a "Pharma View" derived from its long-standing experience in the pharmaceutical industry. This provides portfolio companies with invaluable information and pharma expertise to support their growth. They also facilitate dialogue between portfolio companies and Astellas Pharma, fostering opportunities for future collaborations.